BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 33539847)

  • 1. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.
    Lo Re V; Haynes K; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Leidl KB; Reddy KR; Nezamzadeh MS; Roy J; Sha D; Marks AR; De Boer J; Schneider JL; Strom BL; Corley DA
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2360-8. PubMed ID: 26122767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification.
    Niu H; Solis-Muñoz P; García-Cortés M; Sanabria-Cabrera J; Robles-Diaz M; Romero-Flores R; Bonilla-Toyos E; Ortega-Alonso A; Pinazo-Bandera JM; Cabello MR; Bessone F; Hernandez N; Lucena MI; Andrade RJ; Medina-Caliz I; Alvarez-Alvarez I
    Pharmacol Res; 2024 Jan; 199():107030. PubMed ID: 38072217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
    Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
    J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
    Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
    García-Cortés M; Ortega-Alonso A; Matilla-Cabello G; Medina-Cáliz I; Castiella A; Conde I; Bonilla-Toyos E; Pinazo-Bandera J; Hernández N; Tagle M; Nunes V; Parana R; Bessone F; Kaplowitz N; Lucena MI; Alvarez-Alvarez I; Robles-Díaz M; Andrade RJ
    Liver Int; 2023 Aug; 43(8):1749-1760. PubMed ID: 37269163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
    Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
    Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
    Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
    Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
    Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.
    Medina-Caliz I; Robles-Diaz M; Garcia-Muñoz B; Stephens C; Ortega-Alonso A; Garcia-Cortes M; González-Jimenez A; Sanabria-Cabrera JA; Moreno I; Fernandez MC; Romero-Gomez M; Navarro JM; Barriocanal AM; Montane E; Hallal H; Blanco S; Soriano G; Roman EM; Gómez-Dominguez E; Castiella A; Zapata EM; Jimenez-Perez M; Moreno JM; Aldea-Perona A; Hernández-Guerra M; Prieto M; Zoubek ME; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2016 Sep; 65(3):532-42. PubMed ID: 27184533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.
    Andrade RJ; Lucena MI; Fernández MC; Pelaez G; Pachkoria K; García-Ruiz E; García-Muñoz B; González-Grande R; Pizarro A; Durán JA; Jiménez M; Rodrigo L; Romero-Gomez M; Navarro JM; Planas R; Costa J; Borras A; Soler A; Salmerón J; Martin-Vivaldi R;
    Gastroenterology; 2005 Aug; 129(2):512-21. PubMed ID: 16083708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
    Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
    Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
    Chalasani N; Bonkovsky HL; Fontana R; Lee W; Stolz A; Talwalkar J; Reddy KR; Watkins PB; Navarro V; Barnhart H; Gu J; Serrano J;
    Gastroenterology; 2015 Jun; 148(7):1340-52.e7. PubMed ID: 25754159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI Registry.
    Sanabria-Cabrera J; Sanjuán-Jiménez R; Clavijo E; Medina-Cáliz I; González-Jiménez A; García-Cortés M; Ortega-Alonso A; Jiménez-Pérez M; González-Grande R; Stephens C; Robles-Díaz M; Lucena MI; Andrade RJ;
    Liver Int; 2021 Jul; 41(7):1523-1531. PubMed ID: 33107176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old.
    Weersink RA; Alvarez-Alvarez I; Medina-Cáliz I; Sanabria-Cabrera J; Robles-Díaz M; Ortega-Alonso A; García-Cortés M; Bonilla E; Niu H; Soriano G; Jimenez-Perez M; Hallal H; Blanco S; Kaplowitz N; Lucena MI; Andrade RJ
    Clin Pharmacol Ther; 2021 Apr; 109(4):1147-1158. PubMed ID: 33179256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.